rosiglitazone has been researched along with Choline Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, AS; Chu, ES; Lam, CN; Lee, CW; Sung, JJ; Wong, VW; Wu, CW; Yu, J | 1 |
| Assy, N; Bersudsky, I; Grozovski, M; Hussein, O; Szvalb, S | 1 |
2 other study(ies) available for rosiglitazone and Choline Deficiency
| Article | Year |
|---|---|
PPARgamma is essential for protection against nonalcoholic steatohepatitis.
Topics: Adenoviridae; Animals; Choline Deficiency; Fatty Liver; Gene Transfer Techniques; Genetic Therapy; Methionine; Mice; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.
Topics: Animals; Anticholesteremic Agents; Azetidines; Choline Deficiency; Drug Therapy, Combination; Ezetimibe; Fats; Fatty Liver; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Metformin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tetrazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2006 |